RxDoctor Payments Data

Andrea Colvin, NP

Nurse Practitioner · Mooresville, NCNPI 1053824078

Payments from drug & device makers

$6,090in general payments, 2019–2025

Across 372 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$842
  • Pfizer$615
  • Amgen$374
  • Lilly USA, LLC$272
  • Sumitomo Pharma America, Inc.$242
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$6,090100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,090 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$26,917
Medicare patients
97
Services billed
447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide63$70,614
JardianceEmpagliflozin55$43,675
OzempicSemaglutide29$27,398
EliquisApixaban34$23,759
MyrbetriqMirabegron24$17,980
XareltoRivaroxaban25$14,918
GemtesaVibegron13$8,823
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,668
JanuviaSitagliptin Phosphate13$7,357
TradjentaLinagliptin14$7,252
VyvanseLisdexamfetamine Dimesylate17$6,674
Synjardy XrEmpagliflozin/Metformin Hcl12$3,684
Vilazodone Hcl19$2,211
SynthroidLevothyroxine Sodium25$1,658
Estradiol20$1,510

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$272$70,61463 claims
Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr$242$54,61181 claims
Novo NordiskOzempic$842$27,39829 claims
PfizerEliquis$615$23,75934 claims
Astellas Pharma US IncMyrbetriq$93$17,98024 claims
Johnson & JohnsonXarelto$14$14,91825 claims
Sumitomo Pharma America, Inc.Gemtesa$242$8,82313 claims
AstraZenecaBreztri Aerosphere$149$7,66812 claims
MerckJanuvia$105$7,35713 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$120$6,67417 claims
AbbVieSynthroid$1,172$1,65825 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Mooresville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →